Cardiff Oncology (CRDF) Accumulated Depreciation (2011 - 2026)

Cardiff Oncology has reported Accumulated Depreciation for 8 years, with the latest figure at $4.5 million in Q4 2025.

• Quarterly Accumulated Depreciation rose 7.98% year-over-year to $4.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.5 million (up 7.98% YoY) and the FY2025 annual result came in at $4.5 million, up 7.98% from the prior year.
• Accumulated Depreciation improved to $4.5 million in Q4 2025 per CRDF's latest filing, from $4.4 million in the prior quarter.
• Over five years, Accumulated Depreciation peaked at $4.5 million in Q4 2025 and troughed at $3.8 million in Q4 2023.
• A 3-year average of $4.2 million and a median of $4.2 million in 2024 frame the typical range for Accumulated Depreciation.
• The sharpest annual moves came in 2024 and 2025: Accumulated Depreciation climbed 10.26% in 2024, then gained 7.98% in 2025.
• Over 3 years, Accumulated Depreciation stood at $3.8 million in 2023, then advanced by 10.26% to $4.1 million in 2024, then advanced by 7.98% to $4.5 million in 2025.
• According to Business Quant data, Accumulated Depreciation over the past three periods registered $4.5 million, $4.4 million, and $4.2 million for Q4 2025, Q2 2025, and Q1 2025 respectively.